Grace Therapeutics, Inc. Earnings Per Share, Basic in USD/shares from Q2 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Grace Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2021 to Q3 2025.
  • Grace Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2025 was -0.06 USD/shares, a 80% increase year-over-year.
  • Grace Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was 0 USD/shares, a 43.5% increase year-over-year.
  • Grace Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -0.79 USD/shares, a 41.5% increase from 2023.
  • Grace Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -1.35 USD/shares, a 76.4% increase from 2022.
  • Grace Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -5.71 USD/shares, a 2015% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

Grace Therapeutics, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $0 $0 +$0.24 +80% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-13
Q2 2025 $0 $0 +$0.03 +12.5% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $0 $0.11 +$0.28 Jan 1, 2025 Mar 31, 2025 10-K 2025-06-23
Q4 2024 -$1 $0 $0 -71.4% Oct 1, 2024 Dec 31, 2024 10-Q 2025-02-13
Q3 2024 $0 $0 +$0.13 +30.2% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-13
Q2 2024 -$1 $0 +$0.30 +55.6% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 -$1 $0 +$3.75 +95.7% Jan 1, 2024 Mar 31, 2024 10-K 2025-06-23
Q4 2023 -$5 $0 +$0.31 +59.6% Oct 1, 2023 Dec 31, 2023 10-Q 2025-02-13
Q3 2023 -$5 $0 +$0.23 +34.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$5 -$1 +$0.07 +11.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$5 -$4 -$4 -12967% Jan 1, 2023 Mar 31, 2023 10-K 2024-06-21
Q4 2022 -$1 -$1 $0 -478% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-12
Q3 2022 -$1 -$1 -$1 -2100% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $0 -$1 $0 -408% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $0 $0 Jan 1, 2022 Mar 31, 2022 10-K 2023-06-23
Q4 2021 $0 Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11

Grace Therapeutics, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$1 +$0.56 +41.5% Apr 1, 2024 Mar 31, 2025 10-K 2025-06-23
2023 -$1 +$4.36 +76.4% Apr 1, 2023 Mar 31, 2024 10-K 2025-06-23
2022 -$6 -$5 -2015% Apr 1, 2022 Mar 31, 2023 10-K 2024-06-21
2021 $0 Apr 1, 2021 Mar 31, 2022 10-K 2023-06-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.